UBS Group’s Frontline FRO Stock Holding History

UBS Group’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,000	Closed	-$37K	–	8479
2015 Q2	$37K	Hold	3,000	–	–	﹤0.01%	6276
2015 Q1	$34K	Buy	+3,000	New	+$41.9K	﹤0.01%	6422

Other funds holding FRO

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Keystone Investors Singapore $1.87B AUM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group's FRO Position: Q2 2026 in Review

UBS Group reduced its Frontline (FRO) stake by 4.9% in Q2 2026, selling an estimated $4.48M and leaving 2,390,273 shares worth $83.2M. The position accounts for 0.01% of the portfolio, ranked #1263.

UBS Group first reported a position in FRO in Q4 2014 and has held it in 47 quarters since. The position peaked at $87.6M in Q1 2026. 261 funds tracked by Wall St. Rank hold FRO as of Q2 2026.

UBS Group held 2,390,273 shares of Frontline worth $83.2M as of Q2 2026.
UBS Group sold 122,012 Frontline shares in Q2 2026, an estimated $4.48M.
Frontline made up 0.01% of UBS Group's portfolio in Q2 2026, its #1263 holding.
UBS Group first reported a position in Frontline in Q4 2014 and has held it in 47 quarters since.
UBS Group's Frontline position peaked at $87.6M in Q1 2026.
261 funds tracked by Wall St. Rank held Frontline as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.